Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Founded Year

1998

Stage

Acquired | Acquired

Total Raised

$90.4M

About Metaphore Pharmaceuticals

Metaphore leads the emerging pharmaceutical frontier with its introduction of SOD mimetics, aka superoxide dismutase mimetic (SODm), which mimic, supplement, and enhance the human body's enzyme activity. Methaphore's products can be administered orally or topically as well as made into an aerosol. The company was founded in 1998 by Garland Marshall. Drug maker ActivBiotics plans to acquire the company

Metaphore Pharmaceuticals Headquarter Location

One Bridge Plaza Suite 500

Fort Lee, New Jersey, 07024,

United States

201-582-5000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.